Straumann is a Swiss premium brand and Osstem a high-volume South Korean value brand, and a UK patient will most often see both named in quotes for treatment abroad. The price difference is genuine and the volume difference is large, but neither is a measure of clinical outcome, which studies settle rather than sales.
Side by side
Rows appear only where at least one side has data. Where a value is not verified we say
so rather than leaving it blank.
Attribute
Osstem
Straumann
Parent company
Osstem Implant Co., Ltd., a private company since its 2023 KOSDAQ delistingVerified spec[1][4]
Institut Straumann was founded in 1954 in Waldenburg, Switzerland; the business was refocused exclusively on dental implantology in 1990Verified spec[3]
Institut Straumann was founded in 1954 in Waldenburg, Switzerland; the business was refocused exclusively on dental implantology in 1990Verified spec[3]
Straumann Group (Straumann Holding AG)Verified spec[3]
Current status
Osstem
Not publicly verified
Straumann
Current — the group’s flagship implant brandVerified spec[3]
Geographic availability
Osstem
Sold through subsidiaries across more than 90 countriesManufacturer-reported[1]
Straumann
Not publicly verified
The biggest differences
Straumann is the premium brand of the Straumann Group, refocused exclusively on dental implantology in 1990, and sells several distinct systems using different connections. Osstem, founded in 1997, presents its TS implant as its flagship and is among the most widely placed implants in the world by unit volume. One is a low-volume premium marque, the other a very high-volume value one, and those are commercial descriptions rather than clinical ones.
Prosthetic ecosystem
Neither brand's components fit the other's, and each carries the usual internal caution: 'a Straumann implant' does not name a connection, because the brand runs CrossFit, TorcFit and synOcta across its lines; 'an Osstem implant' does not name the fixture variant, though the TS line at least shares one connection across TS II, III and IV. In both cases the system name is the minimum useful record for future work.
Geographic availability and serviceability
Osstem's very high placement volume and distribution across more than 90 countries make its components widely obtainable, including in the markets where UK patients most often travel. Straumann is internationally distributed but states that not all products are available in all markets. Either way, the connection identified on the implant passport is what determines what a UK dentist can order later.
Cost considerations
Straumann sits in the premium segment and Osstem in the value one. A quote will reflect that. The gap is a market position, not a durability rating, and a patient offered the cheaper brand has been offered a different product rather than a worse one. Where a Straumann Group implant is offered at an unusually low price, it is worth checking whether the product is actually Neodent, the group's value brand, rather than the Straumann marque.
What may influence clinical selection
The deciding factors are clinical and personal, not brand-level: the bone available, the restoration planned, the surgeon's experience with the specific system, and whether the components can be serviced abroad and at home. A brand's price or volume tells you about the market, not about whether it is the right implant for a particular mouth.
So which is better?
Neither is universally better, and any page telling you otherwise is selling something.
These are different designs with different trade-offs, and the right choice depends on the
bone available, the position in the mouth, the planned restoration, and what the treating
clinician is equipped and experienced to place and to service years from now.
That last point is easy to overlook and matters more than most specification
differences: components need to remain obtainable for as long as the implant is in place.
Regulatory record
US FDA 510(k) clearances held by each side, retrieved from the FDA's own database.
Osstem
5
FDA 510(k) clearances
2016 – 2023
Filed by Osstem Implant Co., Ltd.
Straumann
30
FDA 510(k) clearances
2004 – 2026
Filed by Institut Straumann AG
A clearance count is not a quality ranking, and the
larger number is not the better implant. A brand with more clearances usually
has a longer history or a broader component range. FDA "clearance" also is not FDA
"approval" — it means the device was accepted as substantially equivalent to one already
on the market, generally without a clinical trial. A blank here means we could not match
a filing with confidence, not that the brand lacks authorisation.
What these actually mean →
Sources
Numbers match the citations beside each claim above.
